Cybin Inc. Securities Fraud Investigation

Shamis & Gentile, P.A. is investigating claims on behalf of investors of Cybin Inc. ("Cybin" or the "Company") (CYBN). Impacted investors are advised to contact the firm now.

The investigation concerns whether Cybin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. The investigation focuses on potential misrepresentations and omissions by Cybin regarding its clinical trial results and pipeline milestones during the period from approximately June 26, 2024, through September 2, 2025.

On September 2, 2025, Cybin announced the immediate resignation of CEO Doug Drysdale. The same day, Cybin’s stock price fell $1.24 per share, or 16.58%, to close at $6.24, compared to approximately $7.48 prior to the announcement.

Shamis & Gentile, P.A. stands out as an advocate for investors who are victims of securities fraud. The firm is committed to securing recoveries for investors who have incurred damages due to false and misleading statements or other corporate misconduct by public companies. Shamis Gentile has recovered over $1 billion for consumers nationwide. Its extensive experience, expertise and resources enable the firm to resolve disputes in a wide range of matters including class actions, mass torts and mass arbitrations.

Attorney advertising. Prior results do not guarantee similar outcomes.